Serial 98358897
Live / Applied — Second extension granted (statement of use) (as of 11 Nov 2025)
What this means for you
Not registered yet, but its 16 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98358897
- Mark type
- Design / logo
- Filed
- 16 Jan 2024
- Published for opposition
- 17 Sept 2024
- Attorney of record
- Michele K. Robichaux
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic pharmaceuticals for use in oncology, immunology, cardiology, endocrinology, diabetology, pain management, neurology, hematology, dermatology, and critical care; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and therapeutic pharmaceuticals for the prevention and treatment of cancer and cancer-related comorbidities; pharmaceuticals used for stimulating white blood cell production; Pharmaceutical preparations for the treatment of bone diseases, infectious diseases, liver disease, obesity, kidney disease, mental health conditions, Alzheimer's disease, respiratory diseases and disorders, skin disorders, asthma, inflammatory diseases, auto-immune and immune-based disorders, cardiovascular disorders, neurological diseases and disorders, auto-immune and immune-based diseases, and critical illness; Pharmaceutical preparations, namely, anti-diabetics, cardiovascular agents, anti-rheumatics, vaccines, anti-viral medications, immunosuppressants, bronchodilators, anti-coagulants, anti-histamines, anti-inflammatory and anti-arthritic preparations
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing medical and health information to patients in the areas of oncology, immunology, cardiology, endocrinology, diabetology, pain management, neurology, hematology, dermatology, and critical care
Owner
- Accord Biopharma, Inc., Raleigh, NC, US
- Accord Biopharma, Inc., Raleigh, NC, US
Prosecution history
- 11 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Nov 2025 — SOU EXTENSION 2 GRANTED
- 11 Nov 2025 — SOU EXTENSION 2 FILED
- 11 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 05 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 May 2025 — SOU EXTENSION 1 GRANTED
- 05 May 2025 — SOU EXTENSION 1 FILED
- 05 May 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION